Meeting of the Tick-Borne Disease Working Group, 68082 [2020-23693]

Download as PDF 68082 Federal Register / Vol. 85, No. 208 / Tuesday, October 27, 2020 / Notices the final standard MOU is made available for signature before FDA will enforce the 5 percent limit in States that have not signed the MOU, and invited public comment on whether this was an appropriate timeframe. Some commenters on the 2018 revised draft standard MOU stated that more time may be necessary because some States may be required to enact new laws and promulgate new regulations before entering the MOU. Therefore, in response to these comments, FDA is providing a 365-day period for States to decide whether to sign the MOU before FDA intends to begin enforcing the 5 percent limit in States that do not sign. It is FDA’s understanding that this extended timeframe corresponds to a full legislative cycle for most States and should, therefore, afford sufficient time for States to modify their laws and regulations, if necessary. V. Paperwork Reduction Act of 1995 This MOU refers to previously approved collections of information. These collections of information are subject to review by the Office of Management and Budget (OMB) under the Paperwork Reduction Act of 1995 (44 U.S.C. 3501–3521). The collections of information have been approved under OMB control number 0910–0800. VI. Electronic Access Persons with access to the internet may obtain the final standard MOU at either https://www.fda.gov/drugs/ human-drug-compounding/regulatorypolicy-information, https:// www.fda.gov/drugs/guidancecompliance-regulatory-information/ guidances-drugs, or https:// www.regulations.gov. Dated: October 21, 2020. Lauren K. Roth, Acting Principal Associate Commissioner for Policy. [FR Doc. 2020–23687 Filed 10–26–20; 8:45 am] BILLING CODE 4164–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Meeting of the Tick-Borne Disease Working Group Office of the Assistant Secretary for Health, Office of the Secretary, Department of Health and Human Services. ACTION: Notice. jbell on DSKJLSW7X2PROD with NOTICES AGENCY: As required by the Federal Advisory Committee Act, the Department of Health and Human Services (HHS) is hereby giving notice SUMMARY: VerDate Sep<11>2014 18:26 Oct 26, 2020 Jkt 253001 that the Tick-Borne Disease Working Group (TBDWG) will hold a virtual meeting. The meeting will be open to the public. For this meeting, the TBDWG will review chapters and the template for the 2020 report to the HHS Secretary and Congress. The 2020 report will address ongoing tick-borne disease research, including research related to causes, prevention, treatment, surveillance, diagnosis, diagnostics, and interventions for individuals with tickborne diseases; advances made pursuant to such research; federal activities related to tick-borne diseases; and gaps in tick-borne disease research. DATES: The meeting will be held online via webcast on November 17, 2020 from approximately 9:00 a.m. to 5:30 p.m. ET (times are tentative and subject to change). The confirmed times and agenda items for the meeting will be posted on the TBDWG web page at https://www.hhs.gov/ash/advisorycommittees/tickbornedisease/meetings/ 2020-11-17/ when this information becomes available. FOR FURTHER INFORMATION CONTACT: James Berger, Designated Federal Officer for the TBDWG; Office of Infectious Disease and HIV/AIDS Policy, Office of the Assistant Secretary for Health, Department of Health and Human Services, Mary E. Switzer Building, 330 C Street SW, Suite L600, Washington, DC, 20024. Email: tickbornedisease@ hhs.gov; Phone: 202–795–7608. SUPPLEMENTARY INFORMATION: The registration link will be posted on the website at https://www.hhs.gov/ash/ advisory-committees/tickbornedisease/ meetings/2020-11-17/ when it becomes available. After registering, you will receive an email confirmation with a personalized link to access the webcast on November 17, 2020. The public will have an opportunity to present their views to the TBDWG orally during the meeting’s public comment session or by submitting a written public comment. Comments should be pertinent to the meeting discussion. Persons who wish to provide verbal or written public comment should review instructions at https://www.hhs.gov/ash/advisorycommittees/tickbornedisease/meetings/ 2020-11-17/ and respond by midnight November 6, 2020 ET. Verbal comments will be limited to three minutes each to accommodate as many speakers as possible during the 30 minute session. Written public comments will be accessible to the public on the TBDWG web page prior to the meeting. Background and Authority: The TickBorne Disease Working Group was PO 00000 Frm 00050 Fmt 4703 Sfmt 4703 established on August 10, 2017, in accordance with Section 2062 of the 21st Century Cures Act, and the Federal Advisory Committee Act, 5 U.S.C. App., as amended, to provide expertise and review federal efforts related to all tickborne diseases, to help ensure interagency coordination and minimize overlap, and to examine research priorities. The TBDWG is required to submit a report to the HHS Secretary and Congress on their findings and any recommendations for the federal response to tick-borne disease every two years. Dated: October 13, 2020. James J. Berger, Designated Federal Officer, Tick-Borne Disease Working Group, Office of Infectious Disease and HIV/AIDS Policy. [FR Doc. 2020–23693 Filed 10–26–20; 8:45 am] BILLING CODE 4150–28–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Indian Health Service Notice of Listing of Members of the Indian Health Service’s Senior Executive Service Performance Review Board (PRB) Indian Health Service, HHS. Notice; correction of Performance Review Board Membership. AGENCY: ACTION: The Indian Health Service published a notice in the Federal Register on October 14, 2020 listing members of the Indian Health Service’s Senior Executive Service Performance Review Board. The membership listing failed to include Mr. Christopher Mandregan as a member of the Performance Review Board. FOR FURTHER INFORMATION CONTACT: Nathan Anderson, Human Resources Specialist, 5600 Fishers Lane, Rockville, MD 20857, Phone: (605) 681–4940. SUMMARY: Correction In the FR notice of October, 14, 2020, (85 FR 65062), the correction is to the alphabetical listing of Performance Review Board members: Buchanan, Chris Cooper, Jennifer Cotton, Beverly Curtis, Jillian Driving Hawk, James Grinnell, Randy (Chair) Gyorda, Lisa LaRoche, Darrell Mandregan, Christopher Redgrave, Bryce Smith, Ben E:\FR\FM\27OCN1.SGM 27OCN1

Agencies

[Federal Register Volume 85, Number 208 (Tuesday, October 27, 2020)]
[Notices]
[Page 68082]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-23693]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES


Meeting of the Tick-Borne Disease Working Group

AGENCY: Office of the Assistant Secretary for Health, Office of the 
Secretary, Department of Health and Human Services.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: As required by the Federal Advisory Committee Act, the 
Department of Health and Human Services (HHS) is hereby giving notice 
that the Tick-Borne Disease Working Group (TBDWG) will hold a virtual 
meeting. The meeting will be open to the public. For this meeting, the 
TBDWG will review chapters and the template for the 2020 report to the 
HHS Secretary and Congress. The 2020 report will address ongoing tick-
borne disease research, including research related to causes, 
prevention, treatment, surveillance, diagnosis, diagnostics, and 
interventions for individuals with tick-borne diseases; advances made 
pursuant to such research; federal activities related to tick-borne 
diseases; and gaps in tick-borne disease research.

DATES: The meeting will be held online via webcast on November 17, 2020 
from approximately 9:00 a.m. to 5:30 p.m. ET (times are tentative and 
subject to change). The confirmed times and agenda items for the 
meeting will be posted on the TBDWG web page at https://www.hhs.gov/ash/advisory-committees/tickbornedisease/meetings/2020-11-17/ 
when this information becomes available.

FOR FURTHER INFORMATION CONTACT: James Berger, Designated Federal 
Officer for the TBDWG; Office of Infectious Disease and HIV/AIDS 
Policy, Office of the Assistant Secretary for Health, Department of 
Health and Human Services, Mary E. Switzer Building, 330 C Street SW, 
Suite L600, Washington, DC, 20024. Email: [email protected]; 
Phone: 202-795-7608.

SUPPLEMENTARY INFORMATION: The registration link will be posted on the 
website at https://www.hhs.gov/ash/advisory-committees/tickbornedisease/meetings/2020-11-17/ when it becomes 
available. After registering, you will receive an email confirmation 
with a personalized link to access the webcast on November 17, 2020.
    The public will have an opportunity to present their views to the 
TBDWG orally during the meeting's public comment session or by 
submitting a written public comment. Comments should be pertinent to 
the meeting discussion. Persons who wish to provide verbal or written 
public comment should review instructions at https://www.hhs.gov/ash/advisory-committees/tickbornedisease/meetings/2020-11-17/ and 
respond by midnight November 6, 2020 ET. Verbal comments will be 
limited to three minutes each to accommodate as many speakers as 
possible during the 30 minute session. Written public comments will be 
accessible to the public on the TBDWG web page prior to the meeting.
    Background and Authority: The Tick-Borne Disease Working Group was 
established on August 10, 2017, in accordance with Section 2062 of the 
21st Century Cures Act, and the Federal Advisory Committee Act, 5 
U.S.C. App., as amended, to provide expertise and review federal 
efforts related to all tick-borne diseases, to help ensure interagency 
coordination and minimize overlap, and to examine research priorities. 
The TBDWG is required to submit a report to the HHS Secretary and 
Congress on their findings and any recommendations for the federal 
response to tick-borne disease every two years.

    Dated: October 13, 2020.
James J. Berger,
Designated Federal Officer, Tick-Borne Disease Working Group, Office of 
Infectious Disease and HIV/AIDS Policy.
[FR Doc. 2020-23693 Filed 10-26-20; 8:45 am]
BILLING CODE 4150-28-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.